← Back to catalogue
Published

DL-N-carbamoylaspartic acid

vr.tr.dl-n-carbamoylaspartic-acid · thing-q2823324

Enable an agent to recognise the N-carbamoylaspartic acid enantiomer group, distinguish group identity from sample composition, assess a material's identity and condition, and judge its suitability for a specified chemical or analytical use.

Thing Registry Physical world and living systems PHY.MAT

Bundle → Layer → Finding → Questions Filled

6 bundles · 11 layers · 16 findings · 31 questions

Chemical identity and boundaries Establishes which molecular entity and supplied material the DL name denotes.

Connectivity and identifiers

Connects the registry name to structural evidence and qualified external identifiers.

N-carbamoyl connectivity

Require evidence that the carbamoyl group is attached through the aspartic amino nitrogen.

  1. What structural evidence establishes HOOC-CH(NH-CO-NH2)-CH2-COOH for this material? definition
  2. Which identifier records were checked, and do they describe DL material or stereochemistry-unspecified connectivity? provenance

Free-acid boundary

Separates the supplied free acid from salts and solution-dependent ionic states.

Counterion and speciation boundary

Record supplied composition separately from protonation changes following dissolution.

  1. Does counterion analysis support a free acid, a salt or a mixture? measurement
  2. When neutralisation is performed, which resulting salt or solution record should be linked to this substance? boundary
DL composition and biochemical relevance Makes enantiomer proportions explicit and limits transfer of enantiomer-specific evidence.

Enantiomer proportions

Distinguishes an asserted DL label from demonstrated stereochemical composition.

Racemate verification

Treat nominal racemic composition and measured D:L ratio as separate records.

  1. What D:L ratio and uncertainty were measured using a method that resolves the enantiomers? measurement
  2. What tolerance around equal proportions defines acceptable DL material for the intended use? definition
  3. How were the D and L analytical signals assigned? provenance

Stereospecific use

Qualifies applications whose response may depend on the individual enantiomer.

Biochemical evidence transfer

Require explicit justification before applying enantiomer-specific reaction evidence to a DL sample.

  1. Does the cited assay or reaction study use DL material, isolated L material or an unspecified form? provenance
  2. Must the working concentration be expressed as total carbamoylaspartic acid or as a measured individual-enantiomer concentration? action
Lot composition and analytical confidence Determines how much of the weighed material is the intended substance and how confidently it is identified.

Assay and impurities

Qualifies reported content and investigates route-relevant contaminants.

Usable analyte content

Require an assay basis and targeted evidence for plausible impurities rather than interpreting peak area as mass purity.

  1. Is the reported content a calibrated assay, chromatographic area percentage or acid-base titration result? measurement
  2. What evidence addresses residual aspartic acid, urea or other impurities suggested by the documented preparation route? provenance
  3. How are water and residual solvent accounted for in the usable analyte amount? measurement

Orthogonal identification

Combines methods whose limitations are explicit.

Identity evidence coverage

Assess connectivity, bulk composition and enantiomer proportions through appropriate complementary measurements.

  1. Which NMR, mass-spectral or other observations distinguish the intended connectivity from plausible alternatives? measurement
  2. Which identity questions remain unresolved by the available achiral measurements? boundary
Physical state and solution preparation Captures the conditions needed to weigh, dissolve and maintain a usable preparation.

Solid and thermal state

Records observed material form and qualified thermal measurements.

Solid form and thermal events

Distinguish measured melting, water loss and decomposition rather than assigning an unsupported thermal constant.

  1. What evidence establishes the lot's water content and crystalline or amorphous state? measurement
  2. What thermal events were observed, at what heating rate, and were they attributed to melting or decomposition? measurement

Dissolution and ionisation

Defines solution conditions and resulting composition.

Qualified solution concentration

Tie achievable concentration and protonation assessments to measured conditions.

  1. What equilibrium solubility is supported for the chosen solvent, temperature and pH? measurement
  2. What acid-dissociation evidence supports the proposed protonation distribution under those conditions? provenance
  3. What assay correction and added-base record are required to prepare the target concentration reproducibly? action
Stability and handling decisions Connects storage, transformation monitoring and handling requirements to evidence for the actual material.

Storage and transformation

Tracks whether the material retains its qualified composition during storage and use.

Retained chemical and chiral quality

Investigate possible hydrolysis, cyclisation or changes in enantiomer proportions without presuming their occurrence.

  1. What stability data support the specified solid-storage conditions and solution holding time? provenance
  2. Do measurements show hydrolysis, cyclisation products or a changed D:L ratio after the intended exposure conditions? measurement
  3. Which measured changes require requalification or rejection? action

Hazard and regulatory evidence

Matches handling instructions and regulatory identity to the supplied DL material.

Material-specific handling basis

Record documented classifications and evidence gaps without interpreting missing hazard data as safety.

  1. Which current SDS and jurisdictional identifiers explicitly match this free-acid DL material? provenance
  2. What GHS classification and exposure-limit information are documented, absent or unresolved? definition
  3. What controls, incompatibility restrictions and disposal route apply to the planned quantity and operation? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of DL-N-carbamoylaspartic acid this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of DL-N-carbamoylaspartic acid this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of DL-N-carbamoylaspartic acid this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these typical measurements hold for the sense of DL-N-carbamoylaspartic acid this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of DL-N-carbamoylaspartic acid this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of DL-N-carbamoylaspartic acid this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Physical world and living systems
Entry kind
thing
Plane
PHY
Domain
PHY.MAT
Other names and narrower kinds
D-N-carbamoylaspartic acid, N-carbamoyl-L-aspartic acid

What it is Filled

DL-N-carbamoylaspartic acid denotes the group comprising the D and L enantiomers of N-carbamoylaspartic acid, an aspartic acid derivative whose amino nitrogen bears a carbamoyl group; membership in this group does not establish the enantiomer proportions of a material sample.

In scope

  • N-carbamoylaspartic acid connectivity and the D and L members of the enantiomer group.
  • Free-acid identity and relationships to ionised forms, salts and individual enantiomers.
  • The distinction between group membership and a sample's enantiomer proportions.
  • Lot-specific chemical purity, enantiomer proportions, water content and impurities.
  • Solid and solution states under recorded conditions.
  • Analytical suitability, storage evidence and substance-specific safety documentation.

Out of scope

  • Separate models of isolated D and L enantiomers
  • Carbamoylaspartate salts as independently supplied substances
  • Complete pyrimidine biosynthesis pathways and participating enzymes
  • Manufacturing equipment and synthesis processes
  • Formulated products containing this substance
  • Therapeutic efficacy and clinical treatment protocols

Why it exists Filled

Enable an agent to recognise the N-carbamoylaspartic acid enantiomer group, distinguish group identity from sample composition, assess a material's identity and condition, and judge its suitability for a specified chemical or analytical use.

Distinguishing features Filled

  • The required connectivity is HOOC-CH(NH-CO-NH2)-CH2-COOH; the N-carbamoyl group distinguishes it from unmodified aspartic acid, as represented in the linked [PubChem record](https://pubchem.ncbi.nlm.nih.gov/compound/279).
  • The group comprises the D and L enantiomers without requiring that a sample contain both or contain them in equal proportions.
  • An achiral structure record alone cannot establish a sample's enantiomeric composition.
  • Free-acid material must be distinguished from a supplied salt through counterion and composition evidence.
  • Matching molecular mass alone does not establish connectivity, stereochemical composition or material grade.
  • An unspecified ureidosuccinic acid record or an L-specific biochemical annotation cannot by itself establish the composition of a sample associated with this group.

What robots and AI may and may not do Filled

Must not

  • Infer equal enantiomer proportions or sample equivalence to the biological L form from group membership alone.
  • Report supplier data as batch measurements.
  • Recommend human or animal use of a laboratory reagent.

Only with a human decision

  • Using the material in studies involving people or animals.

May

  • Identify the enantiomer group from its name, structure and identifiers without assuming a racemic sample.
  • Distinguish the group from its individual members, including the L enantiomer that occurs in metabolism.

Moral aspects Filled

  • Correct identification protects the validity of research results.
  • Errors in chemical records spread through databases and papers.

Who is affected

  • Researchers
  • Laboratory staff

Owners Filled

Steward

The laboratory or person holding the material; the supplier answers for its stated purity.

Master systems

  • Chemical substance databases

Links to other meta-models Filled

parent

  • Q55524005 - registry parent class
  • Q55525180 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.dl-n-carbamoylaspartic-acid
  • Wikidata: Q2823324 (https://www.wikidata.org/wiki/Q2823324)

Direct properties required Filled

  • Molecular composition: Free acid: C5H8N2O5; reference molar mass 176.13 g/mol. [PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/279)
  • Identifier correspondence: Candidate cross-references: CAS 923-37-5 and PubChem CID 279; verify their stereochemical scope. [PubChem](https://pubchem.ncbi.nlm.nih.gov/compound/279)
  • Enantiomeric composition: D and L mole fractions or D:L ratio, with method and uncertainty
  • Chemical assay: Mass percent or amount fraction; as-received, dry or anhydrous basis
  • Water and counterion content: Water mass percent; counterion identity and molar equivalents
  • Physical form: Observed solid form or solution, with temperature and preparation history
  • Solution condition: Concentration in mol/L, pH, solvent composition and temperature in °C
  • Solubility and thermal behaviour: Solubility in g/L or mol/L; thermal events in °C, with method and decomposition assessment
  • Handling classification: Documented GHS classification, jurisdiction, SDS revision and evidence status

Recognition required Filled

  • A white crystalline powder supplied in labelled containers, so the label and analysis settle identity.
  • Enantiomeric composition can be told only by chiral analysis, not by appearance.

Capabilities and actions required Filled

  • Match a labelled material to the registered substance using structure, stereochemical and counterion evidence.
  • Calculate an assay-corrected amount for a target solution concentration.
  • Select complementary identity, purity and chiral-composition measurements.
  • Accept or reject a lot against requirements for a specified analytical or chemical use.
  • Track condition changes and determine when reanalysis is needed.
  • Retrieve applicable handling and disposal instructions from verified material documentation.

Hazards and failure modes required Filled

  • Mislabelled stereochemistry can invalidate experiments.
  • Fine powders can irritate the eyes and airways.

Standards and interfaces required Filled

  • The Globally Harmonized System of Classification and Labelling of Chemicals, issued by the United Nations, provides the framework for evaluating hazards and communicating any applicable classifications for supplied DL-N-carbamoylaspartic acid materials.

Context of use required Filled

  • DL-N-carbamoylaspartic acid is encountered in chemical and biochemical research involving carbamoylated amino acids.
  • It can be used in analytical method development or studies that compare the behaviour of its D and L enantiomers.
  • Its racemic composition matters in enzyme studies because the two enantiomers may not be accepted equally by a biological system.

Sources Filled

  1. Wikidata item Q2823324: DL-N-carbamoylaspartic acid - identity and sense of the item
  2. Wikipedia: Carbamoyl aspartic acid - general description of the item

Open questions

  • Does the authoritative registry intend a strictly racemic substance or a broader stereochemistry-unspecified entity, and how should overlapping external identifiers be qualified?
  • Which reference method and acceptance tolerance establish the D:L ratio for available material?
  • What verified solubility, acid-dissociation and thermal data apply to a characterised DL free-acid sample?
  • Which storage and solution conditions preserve chemical assay and enantiomer proportions, and which transformation products have actually been observed?
  • Which current primary safety and regulatory records establish the EC identity, GHS classification and any applicable exposure limits for the exact material?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q2823324/spec.json